BRIEF-Lundbeck, Otsuka launches schizophrenia drug in Europe

COPENHAGEN, March 17 Mon Mar 17, 2014 4:05am EDT

Related Topics

COPENHAGEN, March 17 (Reuters) - Danish pharmaceutical company H Lundbeck A/S said on Monday: * Schizophrenia drug Abilify Maintena is now available in a number of European countries * Denmark is the first European country where Abilify Maintena is fully reimbursed * More than ten markets are expected to launch Abilify Maintena by the end of 2014

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

A tourist takes a plunge as she swims at Ngapali Beach, a popular tourist site, in the Thandwe township of the Rakhine state, October 6, 2013. Picture taken October 6, 2013. REUTERS/Soe Zeya Tun (MYANMAR - Tags: SOCIETY) - RTR3FOI0

Where do you want to go?

We look at when to take trips, budget considerations and the popularity of multigenerational family travel.   Video